These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7368659)

  • 1. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
    Vlasov NN; Pliss GB; Balin VV
    Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY; Hayashida S; Pamukcu AM; Bryan GT
    Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
    Imaida K; Wang CY
    Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Arai M; Cohen SM; Jacobs JB; Friedell GH
    J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
    J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions.
    Rowland RG; Henneberry MO; Oyasu R; Grayhack JT
    Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
    Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis.
    Arai M; St John M; Fukushima S; Friedell GH; Cohen SM
    Cancer Lett; 1983 Apr; 18(3):261-9. PubMed ID: 6850560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
    [No Abstract]   [Full Text] [Related]  

  • 18. Desmosome ultrastructure and biological behavior of chemical carcinogen-induced urinary bladder carcinomas.
    Pauli BU; Cohen SM; Alroy J; Weinstein RS
    Cancer Res; 1978 Oct; 38(10):3276-85. PubMed ID: 688217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.